Breast Cancer in Older Women: Trials and Tribulations

Clinical Oncology

Volumn 21, Issue 2, 2009, Pages 99-102

  Reed, M W R ^e   Wyld, L ^a   Ellis, P ^b   Bliss, J ^c   Leonard, R ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB;

BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; DRUG EFFICACY; EDITORIAL; ELDERLY CARE; EVIDENCE BASED MEDICINE; FUNDING; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; MEDICAL AUDIT; MULTIPLE CYCLE TREATMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SYSTEMIC THERAPY;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE;

EID: 59149085212     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.11.014     Document Type: Editorial

References (10)

1. Wyld L., and Reed M.W.R. The need for targeted research into breast cancer in the elderly. Br J Surg 90 (2003) 388-399
2. Bayer A., and Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. Br Med J 321 (2000) 992-993
3. Bugeja G., Kumar A., and Bannerjee A.K. Exclusion of elderly people from clinical research: a descriptive study of published reports. Br Med J 315 (1997) 1059
4. Kornblith A.B., Kemeny M., Peterson B.L., et al. Survey of oncologist's perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 95 (2002) 989-996
5. Early Breast Cancer Trialist's Collaborative Group (EBCTCG). Chemotherapy and hormonal therapy for early breast cancer: effects on recurrence and 15-year survival in an overview of the randomised trials. Available from:. http://www.ctsu.ox.ac.uk/inebctcg
6. Wyld L., Garg D.K., Kumar I.D., Brown H., and Reed M.W. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer 90 (2004) 1486-1491
7. Lavelle K., Todd C., Moran A., Howell A., Bundred N., and Campbell M. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women = 65 years. Br J Cancer 96 (2007) 1197-1203
8. Mustacchi G., Cazzaniga M.E., Pronzato P., De Matteis A., Di Costanzo F., and Floriani I. Breast cancer in elderly women: a different reality? Results from the NORA study. Ann Oncol 18 (2007) 991-996
9. Hind D., Wyld L., and Reed M.W.R. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer 96 (2007) 1025-1029
10. Diab S.G., Elledge R.M., and Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92 (2000) 550-556